Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis protocol

INTRODUCTION: The optimal dose and treatment modality of neoadjuvant radiotherapy applied for treating borderline resectable and locally advanced pancreatic ductal adenocarcinoma (PDAC) have been debated topics in oncology. The objective of the present network meta-analysis (NMA) is to study and com...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Wanrui, Wang, Qingfeng, Hu, Qiancheng, Wang, Xin, Cao, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280870/
https://www.ncbi.nlm.nih.gov/pubmed/35831044
http://dx.doi.org/10.1136/bmjopen-2021-050558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280870/
https://www.ncbi.nlm.nih.gov/pubmed/35831044
http://dx.doi.org/10.1136/bmjopen-2021-050558

Ejemplares similares